Benzinga | Oct 13, 2021 02:02PM EDT

Watching Minerva Neurosciences Shares; Traders Circulate Patent Doc From Australian Gov't. For Co.'s 'Compositions comprising 2-((1-(2(4-Fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-one for treating schizophrenia'

http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do